Libra Infusions Investors

Year Ended	2009-2010	2008-2009	2007-2008	2006-2007	2005-2006
Trading Results
Sales	379294	367527	413776	311657	282442
Operating Profit	34330	27947	28296	25333	20417
Profit before Tax	10247	6030	8848	8607	8469
Taxation	2536	1658	2433	2582	2542
Profit after Tax	7711	4372	6415	6025	5928
Share Capital & Reserves
Paid up Capital	12516	12516	12516	12516	12516
Reserves	4000	4000	4000	0	0
Retained Earning	38367	32534	30352	30128	34103
Shareholder's Equity	1960892	86251	84070	79845	73820
Capital Employed	1960892	86251	84070	79845	73820
Assets Less Liabilities
Current Assets	14183	141615	109658	106009	91650
Current Liabilities	269804	205250	130668	130251	116338
Working Capital	(125621)	(63635)	(21010)	(24242)	(24688)
Fixed Assets (Net)	2260155	283111	195997	179466	154809
Total Net Assets	2404338	424725	305655	285476	246453
Financial Analysis
Operating Profit on sales (%)	9.05%	7.60%	6.84%	8.13%	7.23%
Net Profit on Sales (%)	---	---	---	---	---
Total Net Asset Value per Share (Taka)	15667	689	672	638	590
Return on Shareholders Equity (%)	2	2	2	2	2
Earning per Share (Taka)	62	35	51	48	47
Dividend per Share (Taka)	20.00	15.00	17.50	17.50	17.50
Market Value per Share at year end (Taka)	1900.00	1600.00	1447.25	530.00	483.00
Sponsors General Public & Others Institutions	551	612	687	738	726
ICB including ICB Investors Account	7	7	6	6	5
P/E Ratio (Times)	31	46	28	11	10
Number of Employees at year end	864	811	795	710	688
Number of Shareholder at year end	558	619	693	744	731
*All amount in thousand of taka unless otherwise indicated

Category	2009-2010 (Taka)	2008-2009 (Taka)	2007-2008 (Taka)
Profit & Loss Account:
Turnover net	979394	367527	413776
Gross profit	138605	133644	136481
Net profit before tax	10247	6030	8848
Net profit after tax	7711	4372	6515
Return on paid up capital	61.61%	34.93%	51.25%
Cash Flows & Investments:
Operating activities	---	---	---
Fixed assets	2371679	389820	297806
Financial Position:
Total assets	2404338	424725	305655
Paid up capital	12516	12516	12516
Shareholder's equity	1960892	86251	84070
Earnings per share	61.61	34.93	51.25
Dividend per share	20.00	15.00	17.50

More about Libra Infusions

Products

Investors

Financial statement

Board of Directors

Directors Report

Shareholders

Price Sensitive information

Status of Compliance